Cong Sun

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Monoclonal Antibody

Multiple Sclerosis

Epstein Barr Virus

Top Venues

Signal transduction and targeted therapy

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Jie Yang, Qiao-Li Wang, Guan-Nan Wang, Jia-Cong Ye, Zi-Qian Li, Jing-Yun Wang, Zhao-Hui Liang, Shu-Xin Li, Cong Sun, Wen-Ting Liao, Yi-Jun Gao, Jing Wang, Yong Mao, Chunjing Yu, Guo-Kai Feng, Mu-Sheng Zeng
A pan-KRAS degrader for the treatment of KRAS-mutant cancers. Cell discovery 10 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Chu Xie, Cong Sun, Mu-Sheng Zeng
Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis. Signal transduction and targeted therapy 9 (1) (2024)
Zheng-Zhou Lu, Cong Sun, Xiaolin Zhang, Yingying Peng, Yan Wang, Yan Zeng, Nannan Zhu, Yan Yuan, Mu-Sheng Zeng
Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis. Science advances 9 (21) (2023)
Dong-Chun Hong, Jing Yang, Cong Sun, Yuan-Tao Liu, Lu-Jun Shen, Bu-Shu Xu, Yi Que, Xiaojun Xia, Xing Zhang
Genomic profiling of radiation-induced sarcomas reveals the immunological characteristics and its response to immune checkpoint blockade. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yin-Feng Kang, Cong Sun, Jing Sun, Chu Xie, Zhen Zhuang, Hui-Qin Xu, Zheng Liu, Yi-Hao Liu, Sui Peng, Run-Yu Yuan, Jin-Cun Zhao, Mu-Sheng Zeng
Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants. Nature communications 13 (1) (2022)
Guo-Long Bu, Chu Xie, Yin-Feng Kang, Mu-Sheng Zeng, Cong Sun
How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection. Viruses 14 (11) (2022)
Cong Sun, Run-Yu Yuan, Chu Xie, Jiu-Feng Sun, Xin-Yan Fang, Yi-Sha Hu, Xiao-Hui Yu, Zheng Liu, Mu-Sheng Zeng, Yin-Feng Kang
Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines. Journal of virology 96 (13) (2022)
Xiao Zhang, Junping Hong, Ling Zhong, Qian Wu, Shanshan Zhang, Qianying Zhu, Haiwen Chen, Dongmei Wei, Rui Li, Wanlin Zhang, Xinyu Zhang, Guosong Wang, Xiang Zhou, Junyu Chen, Yinfeng Kang, Zhenghui Zha, Xiaobing Duan, Yang Huang, Cong Sun, Xiangwei Kong, Yan Zhou, Yanhong Chen, Xiaoping Ye, Qisheng Feng, Shaowei Li, Tong Xiang, Song Gao, Mu-Sheng Zeng, Qingbing Zheng, Yixin Chen, Yi-Xin Zeng, Ning-Shao Xia, Xiaoxue Chen
Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion. Proceedings of the National Academy of Sciences of the United States of America 119 (32) (2022)
Cong Sun, Yin-Feng Kang, Yuan-Tao Liu, Xiang-Wei Kong, Hui-Qin Xu, Dan Xiong, Chu Xie, Yi-Hao Liu, Sui Peng, Guo-Kai Feng, Zheng Liu, Mu-Sheng Zeng
Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants. Signal transduction and targeted therapy 7 (1) (2022)
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Yanan Zuo, Lan-Yi Zhong, Shu-Mei Yan, Xiao Zhang, Ziqing Yang, Yong-Jian Peng, Xuanling Shi, Su-Mei Cao, Xinquan Wang, Mu-Sheng Zeng, Linqi Zhang
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature communications 12 (1) (2021)